Insightra Medical raised an unspecified amount in a Series C round co-led by Baird Capital and Tekla Capital Management.
Irvine, Calif.-based Insightra is developing the Freedom inguinal hernia repair device.
Insightra plans to use the proceeds for product development, to grow its U.S. sales force and expand its footprint overseas, according to a press release.
"Baird Capital and Tekla are excellent partners for us due to their significant experience with leading medical devices companies," founder & CEO Brad Sharp said in prepared remarks. "They are very familiar with the space and their expertise, especially with international commercialization, will play a major role in our continued growth."
As part of the deal, Baird Capital partner Michael Liang and Tekla’s Frank Gentile are slated to join Insightra’s board.
"We are excited to be joining Brad and his team to help Insightra expand on its initial success," Liang said in a statement. "Their clinical data across hundreds of patients demonstrating long-term absence of chronic pain and recurrence are the basis by which physician demand will continue to grow. We are also very excited about the international commercial opportunities for all of Insightra’s general surgery products."